Form 4: P&G Director Allen Receives RSU Grant
Insider Transaction Report
Procter & Gamble Director Bertrand Marc Allen was granted 1,475 Restricted Stock Units as part of the company's 2019 Stock and Incentive Compensation Plan.
Summary
- Director Bertrand Marc Allen acquired 1,475 shares of Procter & Gamble Common Stock.
- The transaction occurred on October 14, 2025, at a price of $0 per share.
- These shares represent Restricted Stock Units (RSUs) awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
- The total beneficial ownership of Common Stock by Mr. Allen following this transaction is 10,938.442 shares.
- The total beneficial ownership also includes dividend equivalents in the form of Restricted Stock Units.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged purchase or sale.
Sentiment
Score: 7
Explanation: The grant of RSUs to a director is a positive signal for corporate governance and alignment of interests, reflecting a standard and expected compensation practice. It does not indicate any immediate operational or financial changes, but rather a continuation of established incentive programs.
Positives
- The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, encouraging long-term performance.
- The transaction is part of a pre-arranged 10b5-1 plan, indicating a structured and compliant approach to insider transactions.
Future Outlook
The filing indicates a pre-planned equity award for a director, reflecting ongoing executive compensation strategies under the 2019 Stock and Incentive Compensation Plan.
Industry Context
Equity grants, such as Restricted Stock Units, are a standard component of executive and director compensation across publicly traded companies, particularly in the consumer staples sector. These grants are designed to incentivize long-term performance and align leadership interests with shareholder value creation.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of director compensation is a common practice among large-cap companies, including peers like Unilever (UL), Kimberly-Clark (KMB), and Colgate-Palmolive (CL), which also utilize equity awards to align director incentives with company performance.
- The grant size of 1,475 RSUs is within the typical range for non-executive directors at companies of Procter & Gamble's scale, reflecting a balance between compensation and maintaining independence.
- The transaction being executed under a Rule 10b5-1 plan is a best practice for corporate governance, demonstrating a pre-scheduled and transparent approach to insider trading, similar to practices at companies like Johnson & Johnson (JNJ) and PepsiCo (PEP).
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of Restricted Stock Units under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. | 10/14/2025 | Enhances alignment of director interests with long-term shareholder value through equity ownership. |
| Insider Trading Policy | Transaction made pursuant to a Rule 10b5-1(c) plan. | 10/14/2025 | Demonstrates adherence to best practices for transparent and pre-scheduled insider transactions, reducing potential for accusations of opportunistic trading. |
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's financial interests with long-term company performance, potentially benefiting shareholders through improved governance and strategic decisions.
- Employees: The compensation plan under which the RSUs were granted is part of a broader framework that may also apply to other employees, fostering a culture of shared ownership and performance incentives.
Key Dates
| Date | Description |
|---|---|
| 10/14/2025 | Date of transaction (acquisition of Restricted Stock Units) |
| 10/15/2025 | Date of filing of the Statement of Changes in Beneficial Ownership |
Keywords
Procter & Gamble, PG, Bertrand Marc Allen, Restricted Stock Units, RSU, Insider Transaction, Form 4, Director Compensation, Equity Grant, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.